164 related articles for article (PubMed ID: 11888529)
21. Genotype-dependent impairment of hemoglobin clearance increases oxidative and inflammatory response in human diabetic atherosclerosis.
Purushothaman M; Krishnan P; Purushothaman KR; Baber U; Tarricone A; Perez JS; Wiley J; Kini A; Sharma SK; Fuster V; Moreno PR
Arterioscler Thromb Vasc Biol; 2012 Nov; 32(11):2769-75. PubMed ID: 22982461
[TBL] [Abstract][Full Text] [Related]
22. Association of haptoglobin phenotype with incident acute myocardial infarction in Chinese patients with type 2 diabetes.
Gurung RL; Yiamunaa M; Liu S; Liu JJ; Chan C; Choo RWM; Ang K; Sum CF; Tavintharan S; Lim SC
Cardiovasc Diabetol; 2019 May; 18(1):65. PubMed ID: 31146758
[TBL] [Abstract][Full Text] [Related]
23. Haptoglobin phenotypes in health and disorders.
Sadrzadeh SM; Bozorgmehr J
Am J Clin Pathol; 2004 Jun; 121 Suppl():S97-104. PubMed ID: 15298155
[TBL] [Abstract][Full Text] [Related]
24. Interaction between the Haptoglobin 2 Phenotype and Diabetes Mellitus on Systolic Pulmonary Arterial Pressure and Nitric Oxide Bioavailability in Hemodialysis Patients.
Dahan I; Farber E; Thauho N; Nakhoul N; Francis A; Awawde M; Levy AP; Kim-Shapiro DB; Basu S; Nakhoul F
J Diabetes Res; 2015; 2015():613860. PubMed ID: 26171400
[TBL] [Abstract][Full Text] [Related]
25. Heart rate variability is associated with haptoglobin phenotype in patients with coronary artery disease.
Christensen JH; Krarup HB; Riahi S; Toft E; Schmidt EB
Eur J Cardiovasc Prev Rehabil; 2005 Jun; 12(3):221-5. PubMed ID: 15942419
[TBL] [Abstract][Full Text] [Related]
26. Association between Cys282Tyr missense mutation and haptoglobin phenotype polymorphism in patients with chronic hepatitis C.
Van Vlierberghe H; Delanghe JR; De Bie S; Praet M; De Paepe A; Messiaen L; De Vos M; Leroux-Roels G
Eur J Gastroenterol Hepatol; 2001 Sep; 13(9):1077-81. PubMed ID: 11564959
[TBL] [Abstract][Full Text] [Related]
27. Haptoglobin polymorphism, a genetic risk factor in coronary artery bypass surgery.
Delanghe J; Cambier B; Langlois M; De Buyzere M; Neels H; De Bacquer D; Van Cauwelaert P
Atherosclerosis; 1997 Jul; 132(2):215-9. PubMed ID: 9242967
[TBL] [Abstract][Full Text] [Related]
28. Donor artery stenosis interactions with diastolic blood pressure on coronary collateral flow in type 2 diabetic patients with chronic total occlusion.
Shen Y; Yang ZK; Hu J; Wang XQ; Dai Y; Zhang S; Zhang RY; Lu L; Ding FH; Shen WF
Cardiovasc Diabetol; 2018 Jun; 17(1):76. PubMed ID: 29859086
[TBL] [Abstract][Full Text] [Related]
29. Association of haptoglobin genotype and common cardiovascular risk factors with the amount of iron in atherosclerotic carotid plaques.
Lioupis C; Barbatis C; Drougou A; Koliaraki V; Mamalaki A; Klonaris C; Georgopoulos S; Andrikopoulos V; Bastounis E
Atherosclerosis; 2011 May; 216(1):131-8. PubMed ID: 21316675
[TBL] [Abstract][Full Text] [Related]
30. Haptoglobin genotype is predictive of major adverse cardiac events in the 1-year period after percutaneous transluminal coronary angioplasty in individuals with diabetes.
Roguin A; Koch W; Kastrati A; Aronson D; Schomig A; Levy AP
Diabetes Care; 2003 Sep; 26(9):2628-31. PubMed ID: 12941730
[TBL] [Abstract][Full Text] [Related]
31. The effect of vitamin E supplementation on cardiovascular risk in diabetic individuals with different haptoglobin phenotypes.
Blum S; Vardi M; Levy NS; Miller-Lotan R; Levy AP
Atherosclerosis; 2010 Jul; 211(1):25-7. PubMed ID: 20223458
[No Abstract] [Full Text] [Related]
32. Reduced coronary collateralization in type 2 diabetic patients with chronic total occlusion.
Shen Y; Ding FH; Dai Y; Wang XQ; Zhang RY; Lu L; Shen WF
Cardiovasc Diabetol; 2018 Feb; 17(1):26. PubMed ID: 29422093
[TBL] [Abstract][Full Text] [Related]
33. The effect of vitamin E supplementation on cardiovascular risk in diabetic individuals with different haptoglobin phenotypes.
Levy AP; Gerstein HC; Miller-Lotan R; Ratner R; McQueen M; Lonn E; Pogue J
Diabetes Care; 2004 Nov; 27(11):2767. PubMed ID: 15505023
[No Abstract] [Full Text] [Related]
34. Glycaemic control modifies the haptoglobin 2 allele-conferred susceptibility to coronary artery disease in Type 1 diabetes.
Costacou T; Evans RW; Orchard TJ
Diabet Med; 2016 Nov; 33(11):1524-1527. PubMed ID: 27028131
[TBL] [Abstract][Full Text] [Related]
35. The relationship between fasting blood glucose variability and coronary artery collateral formation in type 2 diabetes patients with coronary artery disease.
Cheng G; Mahmoudi H; Chokshi B; Fernandez M; Kazemi V; Lamaa N
Coron Artery Dis; 2017 Sep; 28(6):486-491. PubMed ID: 28644211
[TBL] [Abstract][Full Text] [Related]
36. Haptoglobin 2-2 Phenotype Is Associated With Increased Acute Kidney Injury After Elective Cardiac Surgery in Patients With Diabetes Mellitus.
Feng C; Naik BI; Xin W; Ma JZ; Scalzo DC; Thammishetti S; Thiele RH; Zuo Z; Raphael J
J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 28982674
[TBL] [Abstract][Full Text] [Related]
37. Haptoglobin phenotype as a predictive factor of mortality in diabetic haemodialysis patients.
Burbea Z; Nakhoul F; Zoabi R; Hochberg I; Levy NS; Benchetrit S; Weissgarten J; Tovbin D; Knecht A; Iaina A; Herman M; Kristal B; Levy AP
Ann Clin Biochem; 2004 Nov; 41(Pt 6):469-73. PubMed ID: 15588436
[TBL] [Abstract][Full Text] [Related]
38. Haptoglobin phenotypes in diabetes mellitus and diabetic retinopathy.
Chandra T; Lakshmi CN; Padma T; Vidyavathi M; Satapathy M
Hum Hered; 1991; 41(5):347-50. PubMed ID: 1778611
[TBL] [Abstract][Full Text] [Related]
39. Haptoglobin phenotype and diabetic nephropathy.
Nakhoul FM; Zoabi R; Kanter Y; Zoabi M; Skorecki K; Hochberg I; Leibu R; Miller B; Levy AP
Diabetologia; 2001 May; 44(5):602-4. PubMed ID: 11380078
[TBL] [Abstract][Full Text] [Related]
40. Haptoglobin polymorphism and complications in established essential arterial hypertension.
Delanghe JR; Duprez DA; De Buyzere ML; Bergez BM; Callens BY; Leroux-Roels GG; Clement DL
J Hypertens; 1993 Aug; 11(8):861-7. PubMed ID: 8228210
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
